SynCore Biotechnology Co LtdSynCore Biotechnology Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by SynCore Biotechnology Co Ltd and you wish to licence your ESG aseessment, please contact us. This webpage of SynCore Biotechnology Co Ltd is assembled by All Street Sevva using advanced AI. The webpage is a free Sustainability analysis covering SynCore Biotechnology Co Ltd.

SynCore Biotechnology Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.0; made up of an environmental score of 0.0, social score of 1.6 and governance score of 1.3.

SDG Transparency Score for SynCore Biotechnology Co Ltd 

1.0

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for SynCore Biotechnology Co Ltd 
0.0

Environmental

1.6

Social

1.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
2499Zhejiang Jolly Pharmaceutical Co Ltd
1.1
Low
2499Yunnan Baiyao Group Co Ltd
1.1
Low
2549SynCore Biotechnology Co Ltd
1.0
Low
2549Benchmark Botanics Inc
1.0
Low
2549HPGC Renmintongtai Pharmaceutical Corp
1.0
Low
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does SynCore Biotechnology Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd offer flexible work?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did SynCore Biotechnology Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has SynCore Biotechnology Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is SynCore Biotechnology Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does SynCore Biotechnology Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does SynCore Biotechnology Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for SynCore Biotechnology Co Ltd
These potential risks are based on the size, segment and geographies of the company.

SynCore Biotechnology Co.,Ltd, a biopharmaceutical company, engages in the research and development, manufacture, and marketing of drugs in the areas of oncology, ophthalmology, and dermatology primarily in Taiwan. The company offers SB03-Veregen, an ointment for the treatment of patients with external genital and perianal warts; and distributes cameras under the epiCam name that is used in recording the progress of ophthalmology diseases. It is also involved in the development of SB01, an injectable anti-cancer new ingredient (NCE) that is in Phase II clinical trials for the treatment of head and neck cancer;SB02, an anti-cancer NCE, which is in preclinical research for use in the treatment of stomach cancer;SB04 that is in Phase II clinical trials for the treatment of patients with dry age-related macular degeneration and SB05, a composition of cytostatic drug paclitaxel combined with neutral and positive lipids, which is in Phase III clinical trials for the treatment of patients with triple negative breast cancer and pancreatic cancer. The company has partnerships with Medigene AG; MacuCLEAR Inc.; Y-YBAR; Epipole Ltd.; Sinphar Pharmaceutical Co., Ltd.; and The National Health Research Institutes. The company was incorporated in 2008 and is headquartered in Yilan City, Taiwan. SynCore Biotechnology Co.,Ltd is a subsidiary of Sinphar Pharmaceutical Co., Ltd.

Sorry!

Failed to process!